As of June 06, 2026, Ironwood Pharmaceuticals's top three insider holders are Alexander J Denner (Director, 9.44Mn shares), Thomas A Mccourt (Chief Executive Officer, 1.90Mn shares), Michael Shetzline (Svp, Cmo, Head Resdrug, 658.04K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Alexander J Denner | - | 256,309 | 9,188,635 | 17 Mar, 2026 |
| Mark G Currie | Chief Scientific Officer | 613,419 | 0 | 12 Jun, 2025 |
| Thomas A Mccourt | Chief Executive Officer | 1,898,838 | 0 | 12 Mar, 2026 |
| Julie Mchugh | - | 208,839 | 0 | 12 Jun, 2025 |
| Jay Shepard | - | 171,555 | 0 | 12 Jun, 2025 |
| Andrew Dreyfus | - | 228,313 | 0 | 12 Jun, 2025 |
| Marla L Kessler | - | 165,883 | 0 | 12 Jun, 2025 |
| Jon R Duane | - | 190,339 | 0 | 12 Jun, 2025 |
| Catherine Moukheibir | - | 117,944 | 0 | 12 Jun, 2025 |
| Jason Rickard | Svp, Chief Operating Officer | 376,316 | 0 | 10 Mar, 2023 |
| Michael Shetzline | Svp, Cmo, Head Resdrug | 658,037 | 0 | 12 Mar, 2026 |
| Ronald Silver | Principal Accounting Officer | 416,570 | 0 | 12 Mar, 2026 |
| Minardo John | Chief Legal Officer | 500,498 | 0 | 12 Mar, 2026 |
| Sravan Kumar Emany | Svp, Coo And Cfo | 309,572 | 0 | 20 Nov, 2024 |
| Andrew Davis | Svp, Chief Business Officer | 284,685 | 0 | 20 Nov, 2024 |
| Gregory S. Martini | Chief Financial Officer | 297,213 | 0 | 12 Mar, 2026 |
| Tammi L Gaskins | Chief Commercial Officer | 350,350 | 0 | 12 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Mar, 2026 | Alexander J Denner | Class A Common Stock | A | 4,451 | $0.00 | 256,309 | D | A |
| 17 Mar, 2026 | Alexander J Denner | Class A Common Stock | D | 6,725,000 | $3.05 | 9,194,435 | I | S |
| 17 Mar, 2026 | Alexander J Denner | Class A Common Stock | D | 5,800 | $3.31 | 9,188,635 | I | S |
| 10 Mar, 2026 | Michael Shetzline | Class A Common Stock | A | 136,612 | $0.00 | 658,037 | D | A |
| 10 Mar, 2026 | Minardo John | Class A Common Stock | A | 136,612 | $0.00 | 500,498 | D | A |
| 10 Mar, 2026 | Gregory S. Martini | Class A Common Stock | A | 136,612 | $0.00 | 297,213 | D | A |
| 10 Mar, 2026 | Thomas A Mccourt | Class A Common Stock | A | 409,836 | $0.00 | 1,898,838 | D | A |
| 10 Mar, 2026 | Ronald Silver | Class A Common Stock | A | 163,934 | $0.00 | 416,570 | D | A |
| 10 Mar, 2026 | Gregory S. Martini | Class A Common Stock | A | 136,612 | $0.00 | 297,213 | D | A |
| 10 Mar, 2026 | Tammi L Gaskins | Class A Common Stock | A | 136,612 | $0.00 | 350,350 | D | A |
| 10 Mar, 2026 | Michael Shetzline | Class A Common Stock | A | 136,612 | $0.00 | 658,037 | D | A |
| 10 Mar, 2026 | Ronald Silver | Class A Common Stock | A | 163,934 | $0.00 | 416,570 | D | A |
| 10 Mar, 2026 | Minardo John | Class A Common Stock | A | 136,612 | $0.00 | 500,498 | D | A |
| 23 Feb, 2026 | Gregory S. Martini | Class A Common Stock | D | 10,487 | $3.81 | 172,058 | D | S |
| 23 Feb, 2026 | Michael Shetzline | Class A Common Stock | D | 15,570 | $3.81 | 538,437 | D | S |
| 23 Feb, 2026 | Gregory S. Martini | Class A Common Stock | D | 10,487 | $3.81 | 172,058 | D | S |
| 23 Feb, 2026 | Thomas A Mccourt | Class A Common Stock | D | 94,757 | $3.81 | 1,592,528 | D | S |
| 23 Feb, 2026 | Ronald Silver | Class A Common Stock | D | 11,552 | $3.81 | 265,257 | D | S |
| 23 Feb, 2026 | Minardo John | Class A Common Stock | D | 17,439 | $3.81 | 382,939 | D | S |
| 23 Feb, 2026 | Ronald Silver | Class A Common Stock | D | 11,552 | $3.81 | 265,257 | D | S |